Press "Enter" to skip to content

AstraZeneca’s Imfinzi misses main goal of advanced lung cancer study – Physician’s Weekly

admin 0

AstraZeneca’s Imfinzi misses main goal of advanced lung cancer study  Physician’s Weekly

Aug 21, 2019 | Reuters | 0 |. AstraZeneca’s Imfinzi misses main goal of advanced lung cancer study. (Reuters) – London-listed drugmaker AstraZeneca Plc said …

“lung cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *